Onychalgia Causes and Mechanisms: The “GIFTED KID” and the “FOMITE”
Athina Fonia et al, 2020, Skin Appendage Disorders CrossRef
Hidden Dangers: Recognizing Excipients as Potential Causes of Drug and Vaccine Hypersensitivity Reactions
Maria Luisa Caballero et al, 2021, The Journal of Allergy and Clinical Immunology: In Practice CrossRef
Silencing Op18/stathmin by RNA Interference Promotes the Sensitivity of Nasopharyngeal Carcinoma Cells to Taxol and High‐Grade Differentiation of Xenografted Tumours in Nude Mice
Xuechi Lin et al, 2016, Basic & Clinical Pharmacology & Toxicology CrossRef
Taxane-related nail toxicity
Giuseppe Schepisi et al, 2015, The Lancet Oncology CrossRef
Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agents
Raul C Maranhão et al, 2017, Expert Opinion on Drug Delivery CrossRef
Mast cells activation and high blood tryptase levels due to paclitaxel administration. Is Cremophor EL the culprit?
Stefano D’Errico et al, 2020, Medicine CrossRef
Co-delivery of siBcl-2 and PTX with mitochondria-targeted functions to overcoming multidrug resistance
Liqiao Zhang et al, 2024, International Journal of Pharmaceutics CrossRef
The Hidden Culprit: A Case of Repeated Anaphylaxis to Cremophor
Young Nam Kim et al, 2016, Allergy, Asthma & Immunology Research CrossRef
Vinblastine differs from Taxol as it inhibits the malignant phenotypes of NSCLC cells by increasing the phosphorylation of Op18/stathmin
Fang Shen et al, 2017, Oncology Reports CrossRef
Predictive factors for taxane acute pain syndrome determined by ordered logistic regression analysis
Yuko Kanbayashi et al, 2019, Supportive Care in Cancer CrossRef
Preclinical studies for the combination of paclitaxel and curcumin in cancer therapy
Yumeng Wei et al, 2017, Oncology Reports CrossRef
A comparative investigation between paclitaxel nanoparticle- and nanocrystal-loaded thermosensitive PECT hydrogels for peri-tumoural administration
Zhiqiang Lin et al, 2016, Nanoscale CrossRef